Overview

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Status:
Completed
Trial end date:
2010-10-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, efficacy and tolerability of perampanel when given as an adjunctive therapy in subjects with refractory partial seizures.
Phase:
Phase 3
Details
Lead Sponsor:
Eisai Inc.